EMD-43660
SARS-CoV-2 S RBD (C.37 Lambda variant) plus S309 Fab, local refinement
EMD-43660
Single-particle3.1 Å
Deposition: 08/02/2024Map released: 27/03/2024
Last modified: 27/03/2024
Sample Organism:
Severe acute respiratory syndrome coronavirus 2,
Homo sapiens
Sample: SARS-CoV-2 S C.37 (Lambda variant) plus S309, S2L20, and S2X303 Fabs
Fitted models: 8vyg
Deposition Authors: McCallum M
,
Veesler D ,
Seattle Structural Genomics Center for Infectious Disease (SSGCID)
Sample: SARS-CoV-2 S C.37 (Lambda variant) plus S309, S2L20, and S2X303 Fabs
Fitted models: 8vyg
Deposition Authors: McCallum M
,
Veesler D ,
Seattle Structural Genomics Center for Infectious Disease (SSGCID)
Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features.
Magaret CA ,
Li L ,
deCamp AC ,
Rolland M ,
Juraska M ,
Williamson BD ,
Ludwig J ,
Molitor C,
Benkeser D ,
Luedtke A,
Simpkins B ,
Heng F ,
Sun Y ,
Carpp LN ,
Bai H ,
Dearlove BL ,
Giorgi EE,
Jongeneelen M,
Brandenburg B,
McCallum M ,
Bowen JE,
Veesler D ,
Sadoff J ,
Gray GE,
Roels S,
Vandebosch A,
Stieh DJ ,
Le Gars M,
Vingerhoets J ,
Grinsztejn B,
Goepfert PA ,
de Sousa LP ,
Silva MST,
Casapia M ,
Losso MH ,
Little SJ ,
Gaur A,
Bekker LG ,
Garrett N ,
Truyers C,
Van Dromme I,
Swann E,
Marovich MA,
Follmann D ,
Neuzil KM ,
Corey L ,
Greninger AL ,
Roychoudhury P ,
Hyrien O,
Gilbert PB
(2024) Nat Commun , 15 , 2175 - 2175
,
Li L ,
deCamp AC ,
Rolland M ,
Juraska M ,
Williamson BD ,
Ludwig J ,
Molitor C,
Benkeser D ,
Luedtke A,
Simpkins B ,
Heng F ,
Sun Y ,
Carpp LN ,
Bai H ,
Dearlove BL ,
Giorgi EE,
Jongeneelen M,
Brandenburg B,
McCallum M ,
Bowen JE,
Veesler D ,
Sadoff J ,
Gray GE,
Roels S,
Vandebosch A,
Stieh DJ ,
Le Gars M,
Vingerhoets J ,
Grinsztejn B,
Goepfert PA ,
de Sousa LP ,
Silva MST,
Casapia M ,
Losso MH ,
Little SJ ,
Gaur A,
Bekker LG ,
Garrett N ,
Truyers C,
Van Dromme I,
Swann E,
Marovich MA,
Follmann D ,
Neuzil KM ,
Corey L ,
Greninger AL ,
Roychoudhury P ,
Hyrien O,
Gilbert PB
(2024) Nat Commun , 15 , 2175 - 2175